US equities
|
NVDA
$150.66
▼-3.09%
MU
$697.31
▼-2.12%
AMD
$521.14
▲+3.52%
SPCX
$143.82
▲+1.50%
SNDK
$765.54
▼-3.98%
TSLA
$382.51
▲+0.63%
AMZN
$267.13
▲+3.58%
AAPL
$352.31
▲+0.11%
NVDA
$150.66
▼-3.09%
MU
$697.31
▼-2.12%
AMD
$521.14
▲+3.52%
SPCX
$143.82
▲+1.50%
SNDK
$765.54
▼-3.98%
TSLA
$382.51
▲+0.63%
AMZN
$267.13
▲+3.58%
AAPL
$352.31
▲+0.11%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about OTCB:SKYE
Recent news which mentions OTCB:SKYE
Skye Bioscience moving ahead with SBI-100 clinical trial after positive safety review
February 24, 2023
Tags
OTCB:SKYE
Skye Bioscience Inc
From
TheNewswire.com - RSS (Media)